logo-loader
OTCMKTS:QRON

Qrons Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$3.93 m
Price
0.30 USD
Change
-25.00%
52 weeks high
2.95
52 weeks low
0.30

In brief

Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. 

Our TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials and a novel delivery system.

We believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients.